Strategic partnerships SNEC collaborates with international partners (Formosa Pharmaceuticals and SERI) on next-generation ophthalmic formulations, signaling openness to co-development, funded research, and external vendor opportunities in advanced drug delivery and formulation services.

Education and training Active initiatives with Singapore Polytechnic to develop Clinical Decision-Making in Community Optometry certification indicate a need for training platforms, e-learning modules, simulation tools, and credentials management that could be offered as scalable programs.

Research leadership As a WHO collaborating centre and national ophthalmic research hub, SNEC/SERI may require high-end data analytics, clinical trial support, regulatory consulting, and secure data infrastructure to bolster research and outcome measurement.

Digital and data readiness Use of technologies like Apache Kafka, Docker, and GDPR compliance suggests a mature tech stack; opportunities exist to provide integration services, data governance, cloud modernization, and security solutions for health data interoperability.

Funding and growth Significant funding events and multi-year grants (e.g., age-related macular degeneration initiatives) indicate capacity for scalable program management, grant reporting tooling, and partnerships with philanthropic or government funding programs.